Why the study?
Does the St. Jude Medical mitral valve improve clinical and hemodynamic outcomes compared to the Björk-Shiley valve in patients undergoing mitral valve replacement?
Does the St. Jude Medical mitral valve improve clinical and hemodynamic outcomes compared to the Björk-Shiley valve in patients undergoing mitral valve replacement?
The St. Jude Medical mitral valve provides superior hemodynamic performance and lower thromboembolic risk at one year compared to the Björk-Shiley valve, making it a good alternative for small prostheses.
No takes yet. Share an insight, caveat, or question.
May favor SJMM over BSM for superior hemodynamics and lower early thromboembolism in mitral replacement; leaves open long-term outcomes in larger cohorts.
Horstkotte et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: